Form 4: RxSight Director Acquires Shares
Statement of Changes in Beneficial Ownership
RxSight, Inc. Director Shweta Maniar acquired 37,037 shares of common stock through restricted stock units.
Summary
- Shweta Maniar, a Director at RxSight, Inc., acquired 37,037 shares of common stock on June 17, 2026.
- These shares were acquired through restricted stock units (RSUs) that vest one year from the grant date or at the next annual stockholder meeting.
- Following this transaction, Maniar beneficially owns 55,172 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard equity grant to a director rather than an open market purchase or sale.
Positives
- Director acquisition of shares can signal confidence in the company's future prospects.
- The acquisition is through RSUs, which are a common form of equity compensation for directors.
Future Outlook
The RSUs are subject to vesting conditions tied to the director's continued service and the company's annual meeting schedule.
Industry Context
StockSavvy.ai notes that director stock acquisitions, particularly through RSUs, are standard practice in the biotechnology and medical device sectors, reflecting long-term alignment with company performance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Shweta Maniar granted power of attorney to specific individuals to execute SEC filings on her behalf. | 02/24/2026 | Facilitates timely and accurate reporting of beneficial ownership changes. |
Stakeholder Impact
- Shareholders: The acquisition by a director may be viewed positively as a sign of commitment, but it does not represent a significant change in ownership structure.
Next Steps
- Vesting of RSUs based on continued directorship and company meeting schedule.
Key Dates
| Date | Description |
|---|---|
| 02/24/2026 | Date of execution of Power of Attorney by Shweta Singh Maniar. |
| 06/17/2026 | Date of grant for Restricted Stock Units and earliest transaction date reported. |
| 06/18/2026 | Date of signature for the Form 4 filing. |
Keywords
RxSight, RXST, Form 4, Director, Stock Acquisition, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.